Register Now
Youtube Linkedin Facebook
dxpx general logo white text

ADLM 2024 Exhibitors:
Secure Your Complimentary Registration for DxPx U.S.

DxPx U.S. is a dedicated industry + investor partnering conference taking place right in the heart of the ADLM 2024 Expo Floor

Tech Scout the most exciting new companies in Diagnostics, Digital Health, Precision Medicine, and Life Science Tools

Complete the Form Below for Your Complimentary
Registration to DxPx U.S. 2024

Benefits for ADLM 2024 Exhibitors Registered at DxPx

More Tech Scouting on the ADLM 2024 Expo Floor = More Value for You

  • While your team attends ADLM 2024, you can send a representative to the DxPx conference area during Expo hours for technology scouting, prime networking opportunities, 1×1 meetings, and more
  • Don’t miss the exciting startups exhibiting in DxPx’s Startup City, presented by Mayo Clinic & Destination Medical Center (DMC)

ADLM 2024 Exhibitors Have Access to All DxPx Networking Opportunities

  • Access to the DxPx Partnering App to pre-schedule 1×1 meetings for July 30th–August 1st
  • Join us for our DxPx Cocktail Reception, presented by AdvaMedDx, on Tuesday, July 30th
  • Watch the 42PLUS1 Pitch Competition Finals live on Wednesday, July 31st

Don't Miss This FREE Opportunity to Maximize Your Time at ADLM 2024

Fill out & submit the form to make the most of your time at the ADLM 2024 Clinical Lab Expo – More Scouting, More Networking, and More Value.

Questions about DxPx? Schedule a time to meet with us and we’ll be happy to assist. 

Want to see more of DxPx U.S.? Click here to view DxPx U.S. 2023 Photo Gallery

Don't miss our investor conferences & early-stage investing events:

dxpx us adlm logos
DxPx US

DxPx Industry & Investor Conference US:
4 Days In-Person

July 29 - Aug. 1, 2024
Chicago, IL
In the ADLM

Stay up to date and sign up for our latest news:

Next: DxPx U.S. 2025
  • 3 Days In-Person
  • July 29 - 31, 2025
  • McCormick Place
    Convention Center
    Chicago, Illinois, USA
Next: DxPx EU 2026
  • 2 Days In-Person
  • Reception: February 5, 2026
    Partnering Day & 42PLUS1:
    February 6, 2026
  • Munich, Germany
Download Brochure
DxPx media
Useful links

© Copyright DxPx 2025. All Rights Reserved.

Youtube Linkedin Facebook

Oliver Dick

Oliver brings 30+ years of experience in the life sciences industry, has worked in pharma, biotechnology and in vitro diagnostics. His areas of expertise fall under Supply Chain Management, Planning, Production, QC, QA, Engineering, Technology Transfer and Process Improvement. Amongst his vast experience, Oliver held functions such as Vice President of Global Manufacturing at QIAGEN, Chief Operating Officer at Miltenyi Biotec or Chief Operating Office of Resolve Biosciences. He demonstrated exceptional leadership and expertise in driving manufacturing excellence on a global scale.

Oliver has a proven ability to streamline processes, optimize production efficiency, and foster a culture of innovation. He was responsible for strategy development, scaling, cost control and quality and was part of multiple M&A projects and transfer of many new products from acquisition or own development. Today Oliver offers his expertise mainly through his own Consultancy Service Company ODICON.

Experience

Christoph Brandenberger

Christoph Brandenberger is a Managing Director at BGL and a leader in the firm’s Diagnostics, Research Tools & Medical Devices investment banking group. He has more than 20 years of experience in all aspects of mergers and acquisitions, commercialization and partnering agreements, and private placements.

A native of Austria and fluent in German, Christoph’s investment banking experience, coupled with his background in international business, has made him a sought-after advisor in both the domestic and international healthcare markets.

Prior to joining BGL, Christoph served as managing director for Healthios Capital Markets, LLC. Christoph started his career as a financial analyst for Bank of America Securities.

Experience

John Riddle

John Riddle is a Managing Director and member of the BGL Executive Committee. He has more than 30 years of investment banking and capital markets experience, advising clients across a broad spectrum of mergers and acquisitions, capital markets activities, and strategic assignments.

John leads BGL’s advisory activities in the Healthcare & Life Sciences investment banking group, which comprises both corporate investment banking and real estate capital markets capabilities. Together with his team, John maintains an ongoing coverage effort with broad activity across several sectors, including health facilities, physician services, and ancillary providers; diagnostics and research tools; medical device and products; and select healthcare technology verticals, including payor services, data analytics, and clinical automation.

Experience

Dr. Mirko Stange

Born in Bremen, Germany in 1974, Dr. Mirko Stange is a diagnostics and life sciences expert with a proven track record in turning around and commercializing innovations. He possesses extensive executive management experience, having led diagnostics and biotech startups, as well as developing and conducting consulting products. Following the completion of his Ph.D. in Biochemistry and Biophysics at the University of North Carolina at Chapel Hill, Dr. Stange began his career in 2004 at the strategy consultancy McKinsey. Subsequently, he worked with the turnaround-specialized advisory firm Droege & Comp., primarily serving clients from the pharma and chemistry industry in Germany and Switzerland.

In 2008, he founded an independent Life Sciences consultancy in Germany where, to date, he leads and directs a team of international experts. This team identifies and funds SMEs with high potential for national and international leverage. In addition to his over ten years of experience in independent corporate finance and management consulting, Mirko Stange provides interim management services to selected clients. To date, three companies co-founded and managed/advised by Dr. Stange have been successfully exited. Leveraging his scientific background, he is also a named inventor on several granted and pending patents.

Experience

FName LName

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Experience